FDA Inspection 1299492 — Kentucky Blood Center Inc.,

Kentucky Blood Center Inc., — FEI 3007689681

The FDA completed an inspection of Kentucky Blood Center Inc., on January 20, 2026 in Lexington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 20, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lexington, KY (United States)